Tim Beissert
11Patents
2h-index
17Co-inventors
43Inventor score
Filing activity: Nov 12, 2013 → Oct 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10717780B2 | Agents for treatment of claudin expressing cancer diseases | Chemistry; Metallurgy | 3 | Active |
| US10093736B2 | Agents for treatment of claudin expressing cancer diseases | Chemistry; Metallurgy | 3 | Active |
| US12291717B2 | RNA replicon for reprogramming somatic cells | Chemistry; Metallurgy | 0 | Active |
| US12338448B2 | Trans-replicating RNA | Chemistry; Metallurgy | 0 | Active |
| US12378531B2 | Use of RNA for reprogramming somatic cells | Chemistry; Metallurgy | 0 | Active |
| US10729784B2 | Method for cellular RNA expression | Chemistry; Metallurgy | 0 | Active |
| US10207009B2 | Method for cellular RNA expression | Chemistry; Metallurgy | 0 | Active |
| US11008550B2 | Use of RNA for reprogramming somatic cells | Chemistry; Metallurgy | 0 | Active |
| US12281322B2 | RNA replicon for versatile and efficient gene expression | Chemistry; Metallurgy | 0 | Active |
| US11168337B2 | RNA replicon for versatile and efficient gene expression | Chemistry; Metallurgy | 0 | Active |
| US11492628B2 | 3′-UTR sequences for stabilization of RNA | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.